Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Improving Preterm Outcomes by Safeguarding Maternal Mental Health

24 de agosto de 2018 actualizado por: Boston Medical Center
The investigators' goal is to optimize the developmental outcomes of preterm infants by preventing depression and improving functioning among their mothers during the critical first year of life. The investigators are conducting a randomized controlled trial of a replicable, lay-delivered intervention - the basic approach of which is to use an empirically-supported, cognitive behavioral strategy to help mothers solve their unique daily problems and address some of the predictable challenges to parenting a preterm infant.

Descripción general del estudio

Estado

Terminado

Descripción detallada

Preterm infants are born at biological risk for poor health and developmental outcomes; and those born to low-income families face additional social risks known to further interfere with healthy child development. In its 2006 report, Preterm Birth, the Institute of Medicine (IOM) stated the public health importance of optimizing the developmental outcomes of preterm infants, and specifically called for novel postnatal intervention strategies to accomplish this goal. Our proposed strategy is based on the premise that preventing maternal depression - and optimizing maternal functioning in specific domains that mediate the relationship between maternal depression and adverse child effects - will ultimately improve the developmental outcomes of this vulnerable child population.

Problem Solving Education (PSE) is a cognitive behavioral strategy that aims to impart recipients with skills to reduce the impact of stress on personal functioning, and thereby prevent depression. The present project is a randomized trial of a 6-session intervention based on PSE. the investigators aim to enroll 325 mother-infant dyads in four NICUs - Boston Medical Center, Tufts Medical Center, Beth Israel Deaconess Medical Center, and Brigham and Womens Hospital. Over 12-months of follow-up, the investigators will assess the effects of PSE on a series of outcome measures for mothers, a series of measures that represent risk mechanisms by which maternal depression is theorized to impact young children, and a series of child functioning measures.

  1. Primary aims. Regarding outcomes for mothers, the investigators aim to:

    1. Decrease the incidence of major depressive episode (MDE) and improve depressive symptom trajectories during the first postpartum year; and
    2. Improve general and parental functioning, as measured by valid and reliable scales.
  2. Secondary aims. Regarding risk mechanisms and child outcomes, the investigators aim to:

    1. Improve mothers' sense of mastery, and decrease their caregiver burden and social isolation;
    2. Improve adherence to evidence-based quality indicators for NICU follow-up care;
    3. Improve maternal sensitivity and mother-child interaction patterns; and
    4. Improve infant social engagement, emotionality, and cognitive functioning.
  3. Exploratory aims. the investigators will explore the role of a brief set of potential intervention moderators:

    1. On the infant level: severity of infant illness.
    2. On the maternal and family level: maternal trauma history, extended family functioning, and intervention adherence.

Tipo de estudio

Intervencionista

Inscripción (Actual)

325

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • Massachusetts
      • Boston, Massachusetts, Estados Unidos, 02215
        • Beth Israel Deaconess Medical Center
      • Boston, Massachusetts, Estados Unidos, 02115
        • Brigham and Women's Hospital
      • Boston, Massachusetts, Estados Unidos, 02111
        • Tufts Medical Center
      • Boston, Massachusetts, Estados Unidos, 02118
        • Boston Medical Center

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

No mayor que 60 años (Niño, Adulto)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Baby is 26-34 weeks gestational age
  • Baby qualifies to receive Medicaid
  • Mother comfortable in English or Spanish
  • Singleton or twin gestation
  • Baby is expected to survive

Exclusion Criteria:

  • Mother in major depressive episode or endorses suicidality
  • Mother with psychosis or otherwise cognitively limited
  • Mother with known active substance use; custody of infant uncertain
  • Infant is critically ill
  • Triplets or higher number gestation
  • Mother who is enrolled in another study receiving the same intervention that we are testing

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Prevención
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Triple

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Problem Solving Education tailored to NICU
NICU-PSE integrates motivational interviewing and problem solving, with ongoing monitoring and linkage to mental health services for mothers with worsening depressive symptoms over time. The intervention is provided over six sessions, including three tailored, post-discharge sessions, which address issues common to families of preterm infants: caregiver burden, complexity of medical follow-up, and social reintegration following hospitalization.
Sin intervención: Control
Both study groups receive standard NICU medical, social work, and nursing services. At each study site, attending neonatologists and pediatrics residents constitute the medical team, and all families are assigned a social worker.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Incidence of major depressive episode and depressive symptom trajectories
Periodo de tiempo: one year
To measure depression and depressive symptom trajectories, we will combine a dimensional measure (the Quick Inventory of Depressive Symptoms - QIDS) with the diagnostic Structured Clinical Interview for DSM-IV Disorders (SCID). Administering the QIDS every other month during this time frame will allow us to follow depression symptom trajectories with a repeated measure sensitive to change with treatment. Administering the SCID at 12-months will allow us to determine timing and severity of major depressive episode(s).
one year
General Functioning
Periodo de tiempo: one year
General functioning will be measured by the mean total SAS-SR score, and mean scores for the family, partner, and social SAS subscales. The SAS will be administered at 6 and 12 months of follow-up.
one year

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Caregiver burden, mastery and social support
Periodo de tiempo: one year
The Coping Health Inventory for Parents is a valid and reliable instrument designed to measure parents' response to managing family life when they have an ill child. It will be administered together with the Pearlin Mastery Scale and the Medical Outcomes Survey Social Support Scale. Administration of these scales will occur at 6 and 12 months of follow-up.
one year
Adherence to recommended NICU follow-up care
Periodo de tiempo: one year

We assess the following measures of adherence to NICU follow-up care:

  • timing and receipt of health supervision visits and immunizations following NICU discharge - including Palivizumab (Synagis).
  • ratio of complaint-based to preventive primary care visits; evaluation for, and attendance to, early intervention services.
one year
Parent-child interaction
Periodo de tiempo: one year
We will videotape and microcode a 10-minute mother-infant free play session according to the parent, infant, and dyadic scales of the Coding Interactive Behavior Manual (CIB). We will assess the following composites: maternal sensitivity; intrusive and withdrawn maternal interactions; and depressed mood and positive affect.
one year
Socio-emotional functioning
Periodo de tiempo: one year
We will assess the CIB infant social engagement composite. We will assess negative infant emotionality using the 4-minute 'Mask Task' of the Laboratory Temperamental Assessment Battery (Lab-TAB).
one year
Cognitive functioning
Periodo de tiempo: one year
We will use the MacArthur-Bates Communicative Development Inventory.
one year

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio

1 de junio de 2013

Finalización primaria (Actual)

25 de mayo de 2018

Finalización del estudio (Actual)

31 de julio de 2018

Fechas de registro del estudio

Enviado por primera vez

2 de julio de 2013

Primero enviado que cumplió con los criterios de control de calidad

5 de julio de 2013

Publicado por primera vez (Estimar)

8 de julio de 2013

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

28 de agosto de 2018

Última actualización enviada que cumplió con los criterios de control de calidad

24 de agosto de 2018

Última verificación

1 de agosto de 2018

Más información

Términos relacionados con este estudio

Términos MeSH relevantes adicionales

Otros números de identificación del estudio

  • H-31407
  • R01HD072069 (Subvención/contrato del NIH de EE. UU.)

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

Indeciso

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir